Matches in Nanopublications for { ?s ?p "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." ?g. }
Showing items 1 to 21 of
21
with 100 items per page.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.